Literature DB >> 7689582

Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.

C Z Lu1, M A Jensen, B G Arnason.   

Abstract

Interleukin 4 (IL-4)- and interferon gamma (IFN gamma)-secreting peripheral blood cells were enumerated by immunospot assay in 13 multiple sclerosis (MS) patients during exacerbations, in 24 patients with progressive multiple sclerosis (CPMS), and in 20 controls. Cells that spontaneously secreted IFN gamma were significantly higher in MS patients experiencing an attack (P < 0.001) than in controls or in CPMS (P < 0.04). IL-4-secreting cell numbers were elevated significantly and to a comparable extent in both MS groups compared to controls. Our finding of increased numbers of IFN gamma-secreting cells is in keeping with prior work showing increased IFN gamma levels in the circulation prior to and during MS attacks and increased release of IFN gamma to the supernatant in bulk cultured blood cells from MS patients. What role an increase in IL-4-secreting cells might play in MS is unclear, but it could relate to immune system regulation. Following in vitro exposure to MBP, IFN gamma-secreting cell number rose above levels observed in the absence of stimulation in controls and in both MS groups with the rise in acutely exacerbating MS patients being significantly greater than in controls. Our results provide further evidence for reactivity to MBP in MS, the significance of which in terms of pathogenesis remains clouded.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689582     DOI: 10.1016/0165-5728(93)90241-p

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.

Authors:  K E Balashov; J B Rottman; H L Weiner; W W Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.

Authors:  S Inogés; J Merino; E Bandrés; P De Castro; M L Subirá; A Sánchez-Ibarrola
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients.

Authors:  L T Nguyen; M Ramanathan; F Munschauer; C Brownscheidle; S Krantz; M Umhauer; C Miller; E DeNardin; L D Jacobs
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.317

Review 6.  Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.

Authors:  Giampaolo Bianchini; Carmine De Angelis; Luca Licata; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2021-11-09       Impact factor: 66.675

7.  Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.

Authors:  Y Zoukos; T N Thomaides; D Kidd; M L Cuzner; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

8.  Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.

Authors:  Ioana R Moldovan; Anne C Cotleur; Natacha Zamor; Robert S Butler; Clara M Pelfrey
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

Review 9.  The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Samuel S Duffy; Justin G Lees; Gila Moalem-Taylor
Journal:  Mult Scler Int       Date:  2014-10-12

10.  A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis.

Authors:  Litza A Kiropoulos; Trevor Kilpatrick; Alex Holmes; Jennifer Threader
Journal:  BMC Psychiatry       Date:  2016-12-07       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.